CSL BEHRING LENGNAU AG (FORMERLY CSL BEHRING RECOMBINANT FACILITY AG

Organization

LEGNAU BE, CH

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Truncated von Willebrand factor polypeptides for extravascular admi...
- Patent number 11,890,327
- Issue date Feb 6, 2024
- CSL BEHRING LENGNAU AG
- Sabine Pestel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Truncated von Willebrand Factor polypeptides for treating hemophilia
- Patent number 11,814,421
- Issue date Nov 14, 2023
- CSL BEHRING LENGNAU AG
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for preparing modified von Willebrand Factor
- Patent number 11,564,976
- Issue date Jan 31, 2023
- CSL Behring Lengnau AG
- Stefan Schulte
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Protein purification and virus inactivation with alkyl glycosides
- Patent number 11,479,578
- Issue date Oct 25, 2022
- CSL BEHRING LENGNAU AG
- Tobias Brandt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modified von Willebrand factor having improved half-life
- Patent number 11,155,601
- Issue date Oct 26, 2021
- CSL BEHRING LENGNAU AG
- Michael Moses
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulation of FVIII immunogenicity by truncated VWF
- Patent number 11,141,466
- Issue date Oct 12, 2021
- CSL BEHRING LENGNAU AG
- Anne Verhagen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for preparing modified von Willebrand factor
- Patent number 10,905,747
- Issue date Feb 2, 2021
- CSL BEHRING LENGNAU AG
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mutated truncated von Willebrand Factor
- Patent number 10,806,774
- Issue date Oct 20, 2020
- CSL BEHRING LENGNAU AG
- Arna Andrews
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mutated von Willebrand factor
- Patent number 10,808,023
- Issue date Oct 20, 2020
- CSL BEHRING LENGNAU AG
- Arna Andrews
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for preparing modified von Willebrand factor
- Patent number 10,772,936
- Issue date Sep 15, 2020
- CSL BEHRING LENGNAU AG
- Stefan Schulte
- G01 - MEASURING TESTING
Information Patent Grant
Truncated von Willebrand factor polypeptides for treating hemophilia
- Patent number 10,688,157
- Issue date Jun 23, 2020
- CSL BEHRING LENGNAU AG
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified von Willebrand Factor
- Patent number 10,253,088
- Issue date Apr 9, 2019
- CSL Behring Lengnau AG
- Michael Wilson
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
FACTOR IX SUBCUTANEOUS ADMINISTRATION WITH ENHANCED SAFETY
- Publication number 20240293516
- Publication date Sep 5, 2024
- CSL Behring Lengnau AG
- Sabine PESTEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABLE COMPOSITIONS OF FC MULTIMERS
- Publication number 20230025806
- Publication date Jan 26, 2023
- CSL Behring Lengnau AG
- Ahmad Mohamad ABDUL FATTAH MOHAMAD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A TRUNCATED VON WILLEBRAND FACTOR (VWF) FOR INCREASING THE IN VITRO...
- Publication number 20220389082
- Publication date Dec 8, 2022
- CSL Behring Lengnau AG
- Hubert METZNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYPEPTIDES FOR INDUCING TOLERANCE TO FACTOR VIII
- Publication number 20220348637
- Publication date Nov 3, 2022
- CSL Behring Lengnau AG
- Marco HOFMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT IgG Fc MULTIMERS FOR THE TREATMENT OF IMMUNE COMPLEX-ME...
- Publication number 20220332847
- Publication date Oct 20, 2022
- CSL Behring Lengnau AG
- Helen Zhihui CAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FACTOR IX VARIANTS AND USES THEREOF IN THERAPY
- Publication number 20220154161
- Publication date May 19, 2022
- CSL Behring Lengnau AG
- Philipp CLAAR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR EXTRAVASCULAR ADMI...
- Publication number 20210268071
- Publication date Sep 2, 2021
- CSL BEHRING LENGNAU AG
- Sabine PESTEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR
- Publication number 20210121535
- Publication date Apr 29, 2021
- CSL BEHRING LENGNAU AG
- Stefan SCHULTE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT IgG Fc MULTIMERS FOR THE TREATMENT OF NEUROMYELITIS OPTICA
- Publication number 20210095006
- Publication date Apr 1, 2021
- CSL BEHRING LENGNAU AG
- Rolf SPIRIG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR
- Publication number 20200368327
- Publication date Nov 26, 2020
- CSL BEHRING LENGNAU AG
- Stefan SCHULTE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEIN PURIFICATION AND VIRUS INACTIVATION WITH ALKYL GLYCOSIDES
- Publication number 20200317727
- Publication date Oct 8, 2020
- CSL BEHRING LENGNAU AG
- Tobias BRANDT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATION OF FVIII IMMUNOGENICITY BY TRUNCATED VWF
- Publication number 20200197495
- Publication date Jun 25, 2020
- CSL Behring Lengnau AG
- Anne VERHAGEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
21-DAY DOSING REGIMEN FOR FUSION PROTEINS COMPRISING FACTOR IX AND...
- Publication number 20200115436
- Publication date Apr 16, 2020
- CSL Behring Lengnau AG
- Yanyan LI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SUBCUTANEOUS ADMINISTRATION OF LONG-ACTING FACTOR IX IN HUMANS
- Publication number 20200093901
- Publication date Mar 26, 2020
- CSL BEHRING LENGNAU AG
- Christine VOIGT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR TREATING HEMOPHILIA
- Publication number 20190263890
- Publication date Aug 29, 2019
- CSL BEHRING LENGNAU AG
- Stefan SCHULTE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
79337443 - AFSTYLA
- Serial number 79337443
- Registration number 7082638
- Filing date Jan 31, 2022
- CSL Behring Lengnau AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79337593 - IDELVION
- Serial number 79337593
- Registration number 7082640
- Filing date Jan 31, 2022
- CSL Behring Lengnau AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90650317 - IDELVION ADVOCATE PROGRAM
- Serial number 90650317
- Filing date Apr 16, 2021
- CSL Behring Lengnau AG
- 36 - Insurance
Information Trademark
79173613 - RELCHAYNE
- Serial number 79173613
- Registration number 4971106
- Filing date Jul 21, 2015
- CSL Behring Recombinant Facility AG
- 5 - Pharmaceutical and veterinary preparations

CSL BEHRING LENGNAU AG (FORMERLY CSL BEHRING RECOMBINANT FACILITY AG

Organization

Patents Grantslast 30 patents

Truncated von Willebrand factor polypeptides for extravascular admi...

Truncated von Willebrand Factor polypeptides for treating hemophilia

Methods for preparing modified von Willebrand Factor

Protein purification and virus inactivation with alkyl glycosides

Modified von Willebrand factor having improved half-life

Modulation of FVIII immunogenicity by truncated VWF

Methods for preparing modified von Willebrand factor

Mutated truncated von Willebrand Factor

Mutated von Willebrand factor

Methods for preparing modified von Willebrand factor

Truncated von Willebrand factor polypeptides for treating hemophilia

Modified von Willebrand Factor

Patents Applicationslast 30 patents

FACTOR IX SUBCUTANEOUS ADMINISTRATION WITH ENHANCED SAFETY

STABLE COMPOSITIONS OF FC MULTIMERS

A TRUNCATED VON WILLEBRAND FACTOR (VWF) FOR INCREASING THE IN VITRO...

POLYPEPTIDES FOR INDUCING TOLERANCE TO FACTOR VIII

RECOMBINANT IgG Fc MULTIMERS FOR THE TREATMENT OF IMMUNE COMPLEX-ME...

FACTOR IX VARIANTS AND USES THEREOF IN THERAPY

TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR EXTRAVASCULAR ADMI...

METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR

RECOMBINANT IgG Fc MULTIMERS FOR THE TREATMENT OF NEUROMYELITIS OPTICA

METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR

PROTEIN PURIFICATION AND VIRUS INACTIVATION WITH ALKYL GLYCOSIDES

MODULATION OF FVIII IMMUNOGENICITY BY TRUNCATED VWF

21-DAY DOSING REGIMEN FOR FUSION PROTEINS COMPRISING FACTOR IX AND...

SUBCUTANEOUS ADMINISTRATION OF LONG-ACTING FACTOR IX IN HUMANS

TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR TREATING HEMOPHILIA

Trademarklast 30 trademarks

79337443 - AFSTYLA

79337593 - IDELVION

90650317 - IDELVION ADVOCATE PROGRAM

79173613 - RELCHAYNE